Amrutanjan Historical Cash Flow

AMRUTANJAN   695.25  1.55  0.22%   
Analysis of Amrutanjan Health cash flow over time is an excellent tool to project Amrutanjan Health Care future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 41.9 M or Depreciation of 35.7 M as it is a great indicator of Amrutanjan Health ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Amrutanjan Health Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amrutanjan Health Care is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amrutanjan Health Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Amrutanjan Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Amrutanjan balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Amrutanjan's non-liquid assets can be easily converted into cash.

Amrutanjan Health Cash Flow Chart

At this time, Amrutanjan Health's Free Cash Flow is very stable compared to the past year. As of the 18th of January 2025, Capital Expenditures is likely to grow to about 79.8 M, while Change To Inventory is likely to drop (752.2 K).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Amrutanjan Health Care to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Amrutanjan Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Amrutanjan Health Care financial statement analysis. It represents the amount of money remaining after all of Amrutanjan Health Care operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Amrutanjan Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Amrutanjan Health Care current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amrutanjan Health Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At this time, Amrutanjan Health's Free Cash Flow is very stable compared to the past year. As of the 18th of January 2025, Capital Expenditures is likely to grow to about 79.8 M, while Change To Inventory is likely to drop (752.2 K).
 2022 2023 2024 2025 (projected)
Capital Expenditures89.3M67.2M60.5M79.8M
Dividends Paid134.5M133.9M153.9M82.8M

Amrutanjan Health cash flow statement Correlations

0.250.40.450.050.010.3-0.51-0.10.17-0.110.23-0.14-0.240.3-0.29-0.150.29-0.41
0.25-0.170.07-0.01-0.230.04-0.21-0.280.480.260.210.22-0.310.27-0.02-0.260.2-0.11
0.4-0.170.8-0.30.140.10.050.71-0.35-0.070.2-0.780.44-0.190.330.54-0.160.17
0.450.070.8-0.06-0.30.24-0.220.32-0.020.360.44-0.74-0.030.340.440.120.320.01
0.05-0.01-0.3-0.06-0.38-0.5-0.32-0.340.870.360.18-0.09-0.160.460.2-0.080.51-0.16
0.01-0.230.14-0.3-0.38-0.020.160.35-0.45-0.62-0.190.190.45-0.68-0.410.27-0.57-0.06
0.30.040.10.24-0.5-0.020.05-0.11-0.41-0.02-0.070.18-0.650.28-0.11-0.62-0.020.06
-0.51-0.210.05-0.22-0.320.160.050.64-0.38-0.17-0.56-0.020.32-0.650.410.23-0.830.78
-0.1-0.280.710.32-0.340.35-0.110.64-0.44-0.1-0.11-0.650.71-0.650.480.73-0.630.52
0.170.48-0.35-0.020.87-0.45-0.41-0.38-0.440.440.260.02-0.290.540.17-0.20.55-0.2
-0.110.26-0.070.360.36-0.62-0.02-0.17-0.10.440.62-0.45-0.310.590.57-0.140.64-0.07
0.230.210.20.440.18-0.19-0.07-0.56-0.110.260.62-0.45-0.080.410.03-0.010.71-0.6
-0.140.22-0.78-0.74-0.090.190.18-0.02-0.650.02-0.45-0.45-0.42-0.04-0.65-0.59-0.16-0.15
-0.24-0.310.44-0.03-0.160.45-0.650.320.71-0.29-0.31-0.08-0.42-0.780.110.95-0.490.15
0.30.27-0.190.340.46-0.680.28-0.65-0.650.540.590.41-0.04-0.780.14-0.60.86-0.27
-0.29-0.020.330.440.2-0.41-0.110.410.480.170.570.03-0.650.110.140.26-0.040.69
-0.15-0.260.540.12-0.080.27-0.620.230.73-0.2-0.14-0.01-0.590.95-0.60.26-0.340.17
0.290.2-0.160.320.51-0.57-0.02-0.83-0.630.550.640.71-0.16-0.490.86-0.04-0.34-0.64
-0.41-0.110.170.01-0.16-0.060.060.780.52-0.2-0.07-0.6-0.150.15-0.270.690.17-0.64
Click cells to compare fundamentals

Amrutanjan Health Account Relationship Matchups

Amrutanjan Health cash flow statement Accounts

202020212022202320242025 (projected)
Change To Inventory62.6M(85.4M)(28.2M)(796K)(716.4K)(752.2K)
Change In Cash(43.2M)(7.2M)27.2M(11.9M)(10.7M)(10.2M)
Free Cash Flow878.0M287.3M102.9M211.9M243.7M255.9M
Change In Working Capital295.1M(39.3M)(106.0M)(101.9M)(91.7M)(87.1M)
Begin Period Cash Flow72.2M29.1M21.9M49.0M44.1M41.9M
Other Cashflows From Financing Activities15.4M99.1M(5.8M)(72.6M)(83.5M)(79.3M)
Depreciation36.7M38.0M52.1M60.6M69.7M35.7M
Other Non Cash Items(88.9M)(106.9M)(117.1M)(131.5M)(118.3M)(124.2M)
Dividends Paid46.8M124.8M134.5M133.9M153.9M82.8M
Capital Expenditures19.6M234.6M89.3M67.2M60.5M79.8M
Total Cash From Operating Activities897.6M522.0M192.2M279.1M321.0M216.9M
Net Income819.0M905.8M536.5M449.7M517.2M360.1M
Total Cash From Financing Activities(63.2M)(167.0M)(140.3M)(482.7M)(434.4M)(412.7M)
End Period Cash Flow29.1M21.9M49.0M37.1M33.4M31.7M
Change To Account Receivables72.6M(209.9M)47.7M(169.7M)(152.7M)(145.1M)
Investments(915.3M)(253.8M)(24.8M)191.7M172.5M181.1M
Total Cashflows From Investing Activities(138.5M)(877.6M)(362.1M)(24.8M)(22.3M)(23.4M)
Other Cashflows From Investing Activities56.4M126.3M64.5M141.2M162.4M170.5M
Change To Netincome(69.7M)(46.0M)(148.6M)(152.3M)(137.0M)(130.2M)
Change To Liabilities16.2M95.0M236.8M(106.7M)(122.7M)(116.5M)
Change To Operating Activities(8.7M)64.9M19.3M(9.2M)(10.6M)(11.1M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Amrutanjan Stock

The Cash Flow Statement is a financial statement that shows how changes in Amrutanjan balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Amrutanjan's non-liquid assets can be easily converted into cash.